Course Outline and Syllabus for Students
|
|
- Elmer Jenkins
- 6 years ago
- Views:
Transcription
1 Course Outline and Syllabus for Students Name: Monica Gautam Course Number: PHM321 Course Title: Selected Topics in Pharmaceutical Industry Course Description: This course is designed to expose students to the pharmaceutical & biopharmaceutical industries, its environment, inner workings, and approach to engaging customers and stakeholders. The course outlines the business model of the and covers both drug development and commercialization, from international and Canadian perspectives. The course is intended to broaden the students understanding of the, introduce critical concepts and terminology, build confidence and prepare students who may seek a career in the. Required: No Elective: Yes Semester: Fall Enrollment: 240 maximum 1. Course Learning Objectives: Upon completion of this course, students will have achieved the following level of learning objectives: Introductory = knowledge and comprehension of concepts, definitions, Intermediate = application of concepts to simple situations Advanced = application of concepts to more complex situations with ability to synthesize and evaluate Knowledge Introductory Level: 1. List and distinguish the rolls of the various stakeholders in industrial pharmacy 2. Explain the role of firms in industrial pharmacy 3. Recognize the need for a financial return on investment for corporate investors in industrial pharmacy 4. List all steps of drug development and commercialization 5. Describe the drug discovery process with a focus on the entrepreneurship and business development 6. Describe the drug development process: bench work, animal testing and clinical development 7. Describe the regulatory environment that governs the pharmaceutical 8. Describe modern market access and drug promotion including the functions of the following departments: health outcomes and economics, medical and scientific affairs, as well as, sales and marketing Intermediate Level: 1. Analyze drug discovery and development strategies and plans 2. Analyze regulatory strategies and plans 3. Analyze market access strategies and plans
2 4. Analyze marketing strategies and plans 5. Discuss the rationale behind major regulations that have shaped the pharmaceutical 6. Differentiate between on-label and off-label promotion and cite the legal implications of off-label promotion 7. Assess when it is appropriate to engage in an off-label discussion Advanced Level: 1. Appraise a drug candidate s potential for commercial success 2. Appraise the success of marketed drugs in the face of emerging competition and other environmental changes 3. Debate controversial regulations and standards governing the such as drug development regulations and new regulations emerging in the field of post licensure market access and health technology assessment Skills Introductory Level: Intermediate Level: 1. Design a simple drug development plan 2. Design a simple market access plan 3. Design a simple marketing plan Advanced Level: Attitudes/Values Introductory Level: 1. Students will gain sufficient knowledge to be able to consider the pharmaceutical as they draw up their career plans Intermediate Level: 1. Develop an appreciation for the history of ethical, legal and regulatory forces that have shaped the pharmaceutical 2. Plan a career with in the pharmaceutical Advanced Level: 1. Formulate a point of view on future trends and opportunities with in the pharmaceutical 2. Rationale for Inclusion in the Curriculum: The industrial pharmacy course will prepare students for interaction with the pharmaceutical. Students will be provided with sufficient background on the s function, structure, stakeholders, incentives and code of conduct. The course will also build on this knowledge base to develop skills and competencies through interaction with actual senior professionals and through in-class discussions of current high profile and controversial topics. As a result, students will be able analyze and understand actions and decisions, appreciate the complexity and limitations imposed on drug development and commercialization, as well as, develop foresight into how the field of industrial pharmacy will develop in the future. In this manner pharmacy students will be able to better define their role while interacting with the and their potential role within
3 the. Further, students will be able to think about how to leverage the pharmaceutical as they progress their careers and profession. 3. Pre-requisites: None 4. Statement of agreement from course coordinators of courses for which this course is a pre-requisite: Not applicable 5. Co-requisites: (for the current and subsequent year) None 6. Statement of agreement from coordinators of courses for which this course is a co-requisite: Not applicable 7. Course Contact Hours and Teaching Methodologies: Didactic (lecture) Large group problem-based or case-based learning Large Group Size (eg 30, 60, 120, 240) Laboratory or Simulation Tutorial/Seminar/Workshop/Small Group Small Group Size (eg 5, 10, 15, 20, 25) Experiential On-line Other (please specify)* * Other specific information: Total course contact hours 26 hours hours persons hours hours persons hours hours hours 26 hours 8. Estimate and description of student's weekly out-of-class preparation time excluding exam preparation: This is estimated at around 2-4 hours per week necessary to work through assigned readings and slides when they are available. 9. Course Coordinator and contact information: Monica Gautam, BScPharm, PharmD monica.gautam@utoronto.ca mgautam@amgen.com Phone: W 10. Course Instructors and contact information: Monica Gautam, BScPharm, PharmD monica.gautam@utoronto.ca mgautam@amgen.com Phone: W
4 11. Required Resources/Textbooks/Readings: Text book Modern Pharmaceutical Industry (A Primer) Jacobsen & Wertheimer Jones and Bartlett publishing 2010 Select publications, see below. 12. Recommended Resources/Textbooks/Readings: None 13. Topic Outline/Schedule: For each, indicate level of knowledge, skills and attitudes learning objectives Week 1 Course overview (Monica Gautam) Review course structure and requirements Overview of pharmaceutical companies and the Knowledge: Introductory List and distinguish the rolls of the various stakeholders in industrial pharmacy Recognize the need for a financial return on investment for corporate investors in industrial pharmacy Skills: Not applicable Attitudes: Introductory Students will gain knowledge to be able to consider the pharmaceutical as they draw up their career plans None Week 2 Honorary Lecture/Panel Discussion/Workshop Roles and Value of the Pharmacist in the Pharmaceutical Industry A facilitated discussion with a panel of at least half a dozen established pharmacists with diverse careers in various aspects of the pharmaceutical.. The discussion will provide a bird s eye view of the and will discuss the s history, current challenges,future trends and how pharmacists provide value. Appraise a drug candidate s potential for commercial success Appraise the success of marketed drugs in the face of emerging competition and other environmental changes
5 Debate controversial regulations and standards governing the such as drug development regulations and new regulations emerging in the field of post licensure market access and health technology assessment Design a simple drug development plan Design a simple market access plan Design a simple marketing plan Attitudes: Advanced Students will gain sufficient knowledge to be able to consider the pharmaceutical as they draw up their career plans Develop an appreciation for the history of ethical, legal and regulatory forces that have shaped the pharmaceutical Plan a career with in the pharmaceutical Formulate a point of view on future trends and opportunities with in the pharmaceutical Review all course material Week 3 Discovery & Innovation 1 ( Industry guest speaker Ayman Chit, MBiotech, PhD) Bench side R&D Startup companies Academic-industrial partnerships Entrepreneurship Cost of R&D Knowledge: Introductory Recognize the need for a financial return on investment for corporate investors in industrial pharmacy List all steps of drug development and commercialization Describe the drug discovery process with a focus on the entrepreneurship and business development Describe the drug development process: bench work, animal testing and clinical development Design a simple drug development plan Attitudes: Introductory Students will gain sufficient knowledge to be able to consider drug discovery and development as they draw up their career plans 1. Jacobsen & Wertheimer CH 1 2. Edwards AM. Too many roads not taken. Nature 470 (2011) ; DIO:1038/470163a
6 3. Koff WC. Accelerating Next-Generation Vaccine Development for Global Disease Prevention. Science 340, (2013); DOI /science Adams CP. Estimating the cost of new drug development: is it really $802 million? Health Affairs, 25, no.2 (2006): Witty A. New strategies for innovation in global health: A Pharmaceutical Industry Perspective. Health Affairs, 30, no.1 (2011): Week 4 Discovery & Innovation 2 and Clinical Development (Industry guest speaker - Michele Caveen, BScPhm, MSc + Monica Gautam) Modern trends in drug discover Overview of the clinical development process Globalization of clinical research Knowledge: Introductory Describe the drug development process: bench work, animal testing and clinical development Design a simple drug development plan Attitudes: Introductory Students will gain sufficient knowledge to be able to consider drug discovery and development as they draw up their career plans 1. Jacobsen & Wertheimer CH 5 & 6 2. Glickman et al. Ethical and Scientific Implications of Globalization of Clinical Research. The New England Journal of Medicine. (2009) 360; 8: Week 5 Pharmaceutical regulation (Industry guest speaker + Monica Gautam) Regulating Research and Development Regulating promotional activities History and future challenges of modern regulation Knowledge: Intermediate Describe the regulatory environment that governs the pharmaceutical
7 Analyze drug discovery and development strategies and plans Analyze regulatory strategies and plans Analyze market access strategies and plans Attitudes: Intermediate Students will gain sufficient knowledge to be able to consider regulatory affairs as they draw up their career plans Develop an appreciation for the history of ethical, legal and regulatory forces that have shaped the pharmaceutical 1. Jacobsen & Wertheimer CH 7 2. Hamburg. Innovation, Regulation and the FDA. The New England Journal of Medicine. (2010) 363: Week 6 Medical and Scientific Affairs I (Safety & Medical Information) (Industry guest speaker, Maureen Bot BScPhm + Monica Gautam) Ensuring that marketing strategy is grounded in scientific and medical principles Compliance in the pharmaceutical Managing off label discussions Describe modern market access and drug promotion including the functions of the following departments: health outcomes and economics, medical and scientific affairs, as well as, sales and marketing Discuss the rationale behind major regulations that have shaped the pharmaceutical Differentiate between on-label and off-label promotion and cite the legal implications of off-label promotion Assess when it is appropriate to engage in an off-label discussion Debate controversial regulations and standards governing the such as drug development regulations and new regulations emerging in the field of post licensure market access and health technology assessment Design a simple marketing plan Design a simple market access plan Attitudes: Intermediate Students will gain sufficient knowledge to be able to consider medical and scientific affairs as they draw up their career plans Develop an appreciation for the history of ethical, legal and regulatory forces that have shaped the pharmaceutical 1. Jacobsen & Wertheimer CH Van Buynder et al. Marketing Pediatric influenza vaccination: results of a major metropolitan trial. Influenza and Other Respiratory Viruses. (2011) 5(1), Kesselheim et al. FDA Regulation of Off-label Drug Promotion Under Attack. Journal of the American Medical Association. (2013) 309(5),
8 Week 7 Medical and Scientific Affairs II (Medical Education & MSLs) (Industry guest speakers, Michele Caveen BScPhm, MSc, Willena Talbot BScPharm, PhD, Natalie Meyer BSc, MSc + Monica Gautam) Ensuring that marketing strategy is grounded in scientific and medical principles Compliance in the pharmaceutical Managing off label discussions Describe modern market access and drug promotion including the functions of the following departments: health outcomes and economics, medical and scientific affairs, as well as, sales and marketing Discuss the rationale behind major regulations that have shaped the pharmaceutical Differentiate between on-label and off-label promotion and cite the legal implications of off-label promotion Assess when it is appropriate to engage in an off-label discussion Debate controversial regulations and standards governing the such as drug development regulations and new regulations emerging in the field of post licensure market access and health technology assessment Design a simple marketing plan Design a simple market access plan Attitudes: Intermediate Students will gain sufficient knowledge to be able to consider medical and scientific affairs as they draw up their career plans Develop an appreciation for the history of ethical, legal and regulatory forces that have shaped the pharmaceutical 1. Jacobsen & Wertheimer CH Van Buynder et al. Marketing Pediatric influenza vaccination: results of a major metropolitan trial. Influenza and Other Respiratory Viruses. (2011) 5(1), Kesselheim et al. FDA Regulation of Off-label Drug Promotion Under Attack. Journal of the American Medical Association. (2013) 309(5), Week 8 Recommending bodies and payers 1 (Industry guest speaker, Ayman Chit+ Monica Gautam) Cost effectiveness thresholds Cost effectiveness analysis in Canada and the US Describe modern market access
9 Analyze market access strategies and plans Appraise a drug candidate s potential for commercial success Appraise the success of marketed drugs in the face of emerging competition and other environmental changes Debate controversial regulations and standards governing the such as drug development regulations and new regulations emerging in the field of post licensure market access and health technology assessment Design a simple market access plan Attitudes: Intermediate Students will gain sufficient knowledge to be able to consider market access and health economics as they draw up their career plans Develop an appreciation for the history of ethical, legal and regulatory forces that have shaped the pharmaceutical 1. Jacobsen & Wertheimer CH Neumann PJ. Legislation against use of cost-effectiveness information. New England Journal of Medicine. (2010) 363; 16: Towse A. Should NICE's threshold range for cost per QALY be raised? British Medical Journal. (2009) v.338: : b181 Week 9 Class assignments and Facilitated Discussions (Monica Gautam) Attitudes: Advanced Review class assignment Week 10 Pharmaceutical Marketing (Industry guest speakers Mirjana Chionglo BScPhm, PharmD, Taffik Choudhury BScPhm + Monica Gautam) Developing a marketing plans for all phases of a drug s life cycle Assessing the impact of marketing campaign Describe the marketing process Analyze a marketing plan Appraise a drug candidate s potential for commercial success Appraise the success of marketed drugs in the face of emerging competition and other environmental changes Debate controversial regulations and standards governing the such as drug development regulations and new regulations emerging in the field of post licensure market access and health technology assessment
10 Develop a simple marketing plan Attitudes: Intermediate Students will gain sufficient knowledge to be able to consider marketing as they draw up their career plans Develop an appreciation for the history of ethical, legal and regulatory forces that have shaped the pharmaceutical 1. Jacobsen & Wertheimer CH Van Buynder et al. Marketing Pediatric influenza vaccination: results of a major metropolitan trial. Influenza and Other Respiratory Viruses. (2011) 5(1), Kesselheim et al. FDA Regulation of Off-label Drug Promotion Under Attack. Journal of the American Medical Association. (2013) 309(5), Week 11 Recommending bodies and payers 2 (Industry guest speaker, Manny Papadimitropoulos + Monica Gautam) Overview of recommending bodies and post-licensure market access Global industrial perspective on reimbursement, health outcomes and economics Knowledge: Introductory Describe modern market access Design a simple market access plan Attitudes: Introductory Students will gain sufficient knowledge to be able to consider market access and health economics as they draw up their career plans 1. Jacobsen & Wertheimer CH Neumann PJ. Legislation against use of cost-effectiveness information. New England Journal of Medicine. (2010) 363; 16: Towse A. Should NICE's threshold range for cost per QALY be raised? British Medical Journal. (2009) v.338: : b181
11 Week 12 Vaccines (Industry guest speaker) Overview of the vaccines in Canada and around the world Overview of the market place for vaccines How vaccines are different from medicines in terms of R&D, manufacturing, regulatory environment, as well as, payers and recommendations Describe the vaccine discovery, development, manufacturing and commercialization process Recognize the differences and similarities between the vaccine and pharmaceutical industries Appraise a vaccine candidate s potential for commercial success Appraise the success of marketed vaccines in the face of emerging competition and other environmental changes Debate controversial regulations and standards governing the such as vaccine development regulations and new regulations emerging in the field of post licensure market access and health technology assessment Design a simple vaccine development plan Design a simple vaccine market access plan Design a simple vaccine marketing plan Attitudes: Intermediate Students will gain sufficient knowledge to be able to consider the vaccine as they draw up their career plans Develop an appreciation for the history of ethical, legal and regulatory forces that have shaped the vaccine Koff WC. Accelerating Next-Generation Vaccine Development for Global Disease Prevention. Science 340, (2013); DOI /science Week 13 Course and exam review (Monica Gautam) Attitudes: Advanced Review all course material 14. Assessment Methodologies Used:
12 Multiple Choice questions (MCQs) Short essay Class participation Learning Objectives Addressed Assessment 1: Midterm examination: covering lectures 1 to 5 inclusive of assigned readings Assessment 2: Short essay assessing intermediate and advanced learning objectives Assessment 3: Class participation Assessment 4: Final exam: covering all lectures and assigned readings Assessment Method Used Assessment 1: Multiple Choice questions (MCQs) Assessment 2: Short essay Assessment 3: Students will be graded based on in-class participation. Comment/question can be made either verbally in class or on a comment card submitted at the end of class. Marks are assigned for simply making/asking comments/questions, as well as, the quality of the participation. Assessment 4: Multiple Choice questions (MCQs) When Administered Assessment 1: During midterm period Assessment 2: Due at start of lecture 13 Assessment 3: Throughout the course, ends after the final lecture Assessment 4: During final exam period Percentage of Course Grade Assessment 1: 30% Assessment 2: 20% Assessment 3: 10% Assessment 4: 40% For Group Work (maximum 10% of course grade) indicate how marks within groups are allocated: Individualized or Same for all Group Members Assessment 1: Assessment 2: Assessment 3: Assessment 4: Remediation Opportunities? Assessment 1: As per university policy see section 15 below Assessment 2: As per university policy see section 15 below Assessment 3: No Assessment 4: As per university policy see section 15 below Expectation for pass grades for all Pharmacy courses is 60%. 15. Policy and procedure regarding make-up assignments/examinations/laboratories:
13 Missed Exam/Test Policy: Students who miss an examination or a test and who have a valid petition filed with the Registrar s office will be eligible to complete a make-up examination or test. This will be an oral examination. Missed Assignment Policy: Students who fail to submit an assignment by the specified due date, and who have a valid petition filed with the Registrar s office will be eligible to submit the completed assignment with no academic penalty. Late Assignment Policy: Students who fail to submit an assignment by the specified due date will receive a deduction of 10% for each day beyond the due date (including weekends/holidays), to a maximum of 50%. Assignments will not be accepted for grading after 7 late calendar days.
Translational scientist competency profile
C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective
More informationSAULT COLLEGE OF APPLIED ARTS AND TECHNOLOGY SAULT STE. MARIE, ONTARIO COURSE OUTLINE
SAULT COLLEGE OF APPLIED ARTS AND TECHNOLOGY SAULT STE. MARIE, ONTARIO COURSE OUTLINE COURSE TITLE: Technology and Society CODE NO. : SEMESTER: ANY PROGRAM: AUTHOR: General Education Course (any program)
More informationTechnology Leadership Course Descriptions
ENG BE 700 A1 Advanced Biomedical Design and Development (two semesters, eight credits) Significant advances in medical technology require a profound understanding of clinical needs, the engineering skills
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationPROGRAM ANNOUNCEMENT. New Jersey Institute of Technology. MSPhM Systems Engineering. Newark. Fall 2008
PROGRAM ANNOUNCEMENT November 2007 Institution: New Program Title: Degree Designation: Degree Abbreviation: CIP Code and Nomenclature (if possible): Campus(es) where the program will be offered: Date when
More informationÓbuda University Donát Bánki Faculty of Mechanical and Safety Engineering. TRAINING PROGRAM Mechatronic Engineering MSc. Budapest, 01 September 2017.
Óbuda University Donát Bánki Faculty of Mechanical and Safety Engineering TRAINING PROGRAM Mechatronic Engineering MSc Budapest, 01 September 2017. MECHATRONIC ENGINEERING DEGREE PROGRAM CURRICULUM 1.
More informationDo not copy BME Abbreviated Course Title (19 spaces or less): Design of Biomedical Systems and Devices
without the express written consent of the instructor. Department of Biomedical Engineering Course Title: Design of Biomedical Systems & Devices Instructors: Michael Christie/ Hamid Shahrestani Required
More informationFDA Centers of Excellence in Regulatory and Information Sciences
FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in
More informationIntellectual Property, Vaccine Production and Technology Transfer
Intellectual Property, Vaccine Production and Technology Transfer Vaccine Industry Perspective P. Fournier, On behalf of IFPMA Bio Group 19-20 April 2004, WHO HQ, Geneva 1 OUTLINE General considerations
More informationCTPR 438 PRACTICUM IN PRODUCING SYLLABUS 2 UNITS. USC SCHOOL OF CINEMATIC ARTS Spring 2018
CTPR 438 PRACTICUM IN PRODUCING SYLLABUS 2 UNITS USC SCHOOL OF CINEMATIC ARTS Spring 2018 Pre-requisite: MEETING TIMES: CTPR 310 - Intermediate Production or CTPR 425 - Production Planning Thursday 6:00
More informationSJSU Annual Program Assessment Form Academic Year
SJSU Annual Program Assessment Form Academic Year 2015 2016 Department: Computer Science Program: BSCS College: Science Program Website: http://www.sjsu.edu/cs/ Link to Program Learning Outcomes (PLOs)
More informationDecember Eucomed HTA Position Paper UK support from ABHI
December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing
More informationAn Essential Health and Biomedical R&D Treaty
An Essential Health and Biomedical R&D Treaty Submission by Health Action International Global, Initiative for Health & Equity in Society, Knowledge Ecology International, Médecins Sans Frontières, Third
More informationInnovation in HTA: What is the additional value?
Innovation in HTA: What is the additional value? Stirling Bryan Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute School of Population & Public Health, UBC My co-authors
More informationPROGRAM ASSESSMENT PLAN ~ through This document only needs to be updated when changes are made.
PROGRAM AEMENT PLAN ~ 2013-14 through 2018-19 UNIT Department (if applicable) Degree/Program CHOOL OF BUINE N/A Date Prepared July 17, 2015 Date Revised Bachelor of Business Administration Updated to New
More informationA Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data
External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on
More informationDisney Corporate Analysis Course
Disney Corporate Analysis Course Contact: College Program Education Suite #703, Vista Way Tel: (407) 827-1244 P.O. Box 10000 Fax: (407) 560-8899 Lake Buena Vista, FL 32830 THE DISNEY CORPORATE ANALYSIS
More informationDigital Health Startups A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in
More informationChess Course Syllabi Table of Contents
Chess Course Syllabi Table of Contents Chess... 2 CP 422: Basic Chess Strategy Part 1 (in English)... 2 CP 432: Basic Chess Strategy Part 2 (in English)... 4 CP 442: Intermediate Chess Strategy Part 1
More informationANNUAL PROGRAM REPORT
ACADEMIC SENATE Committee on Academic Planning and Review ANNUAL PROGRAM REPORT College CLASS Department PUAD Program MS-HCA Reporting for Academic Year 2016-17 Last 5-Year Review 2011-12 Next 5-Year Review
More informationRESEARCH PROGRAMME MANAGER for the AntiMicrobial Resistance Benchmark
RESEARCH PROGRAMME MANAGER for the AntiMicrobial Resistance Benchmark The Access to Medicine Foundation is looking for an experienced researcher and manager who will lead the research team in charge of
More informationCanada s Research-Based Pharmaceutical Companies (Rx&D) 2015 Pre-Budget Submission House of Commons Standing Committee on Finance.
Canada s Research-Based Pharmaceutical Companies (Rx&D) 2015 Pre-Budget Submission House of Commons Standing Committee on Finance August 6, 2014 Ottawa, Ontario Introduction Rx&D represents more than 50
More informationVirtual Journal Club. Guest Faculty. Definitions
Virtual Journal Club Bottom Line Funding in the US and Canada: Commercialization Strategies for Planned Change Friday, December 4, 2009 1:00 2:00 Pm ET Guest Faculty Paul Mazmanian, PhD Editor, Journal
More informationBA (Hons) Photography Length of Course
Programme Specification Every taught course of study leading to a UAL award is required to have a Programme Specification. This summarises the course aims, learning outcomes, teaching, learning and assessment
More informationMGMT 452 Family Business Management COURSE SYLLABUS Fall 2013
SAN DIEGO STATE UNIVERSITY COLLEGE OF BUSINESS ADMINISTRATION MGMT 452 Family Business Management COURSE SYLLABUS Fall 2013 Instructor: Office Hours: Office: E-mail: Carmen Bianchi Mondays 3:00pm-3:45pm
More informationPharmaceutical Promotion in Medical (and Pharmacist) Training in the Netherlands: Readiness for Curriculum Change
Pharmaceutical Promotion in Medical (and Pharmacist) Training in the Netherlands: Readiness for Curriculum Change Brian Tielrooij September 7th, 2017 Introduction Indispensable role of medicines in society
More informationEE (3L-1.5P) Analog Electronics Department of Electrical and Computer Engineering Fall 2015
EE 221.3 (3L-1.5P) Analog Electronics Department of Electrical and Computer Engineering Fall 2015 Description: Introduction to solid state electronics. Emphasis is on circuit design concepts with extensive
More informationTECHNOLOGY BACHELOR DEGREE (HEALTH SCIENCES OR ENGINEERING AND APPLIED SCIENCE OPTIONS) Prepare for a career as a technology leader.
TECHNOLOGY (HEALTH SCIENCES OR ENGINEERING AND APPLIED SCIENCE OPTIONS) BACHELOR DEGREE Prepare for a career as a technology leader. PROGRAM DESCRIPTION The Bachelor of Technology program prepares graduates
More informationC A P I L A N O UNIVERSITY COURSE OUTLINE TERM: Fall 2014 COURSE NO.: IDF 233
C A P I L A N O UNIVERSITY COURSE OUTLINE TERM: Fall 2014 COURSE NO.: IDF 233 INSTRUCTORS: COURSE NAME: Screenwriting OFFICE: LOCAL: SECTION NO.: COURSE CREDITS: 3 MISSION STATEMENT: The Indigenous Independent
More informationIssues in Emerging Health Technologies Bulletin Process
Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The
More informationPharmaceutical Industry and Public Policy SPEA-H 455 Spring 2016 Monday Wednesday 1:00 2:15, AC C112
Pharmaceutical Industry and Public Policy SPEA-H 455 Spring 2016 Monday Wednesday 1:00 2:15, AC C112 Professor Victoria Perez Office: SPEA 375 G vieperez@indiana.edu To make sure your email does not get
More informationNEWS RELEASE. Life sciences companies tout their expertise in India
For Immediate Release 2014MIT0016-000196 Feb. 19, 2014 NEWS RELEASE International Trade and Responsible for the Asia Pacific Strategy and Multiculturalism Life sciences companies tout their expertise in
More informationSupporting Innovation through Regulation and Science
Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers
More informationChemical and Biological Engineering Student Learning Outcome Assessment Report
Chemical and Biological Engineering Student Learning Outcome Report 1. Department/Program Mission The mission of the Department of Chemical and Biological is to prepare chemical engineers for successful
More informationEssay Questions. Please review the following list of questions that are categorized by your area of certification. The six areas of certification are:
Essay Questions Please review the following list of questions that are categorized by your area of certification. The six areas of certification are: Environmental Assessment Environmental Documentation
More informationDraft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
More informationABHI Response to the Kennedy short study on Valuing Innovation
ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.
More informationIntroduction to STP (Clinical Science) Clinical Pharmaceutical Sciences
Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences Manchester Pharmacy School 9 Professors 18 Lecturers/Senior Lecturers/Reader 29 Post doc researchers 7 Teaching Fellows/Senior Teaching
More informationNew & Small Business Ventures MGT 244 Spring Qt COURSE SYLLABUS
New & Small Business Ventures MGT 244 Spring Qt. 2003 COURSE SYLLABUS Instructor: Office Hrs.: E-mail: Fernando Garcia, M.B.A., J.D. 257 AOB IV, Wednesdays, 1:30 2:45 PM, or by appt. fogarcia@ucdavis.edu
More informationDISCIPLINE DESCRIPTION
DISCIPLINE DESCRIPTION 1. Information about the program 1.1 Higher education Babeş-Bolyai University institution 1.2 Faculty Faculty of Political, Administrative and Communication Sciences 1.3 Department
More informationHTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:
HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually
More informationHow can value be measured and assessed?
Dávid Dankó, PhD, MSc Corvinus University of Budapest Institute of Management david.danko at uni-corvinus.hu How can value be measured and assessed? ISPOR 5 th Asia-Pacific Conference, Taipei, 2 September
More information2008 Course Programs Schedule
2008 Course Programs Schedule Basic Laboratory Safety Laboratory Safety Biostatistics for the Non-Statistician - Basic Applied cgmps for Pharmaceutical and Allied Industries Good Clinical Practices (GCP)
More informationDiscovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.
Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology
More informationDecision regarding PHARMAC s Implementation of Trans-Pacific Partnership (TPP) provisions and other Amendments to Application Processes
8 December 2016 Decision regarding PHARMAC s Implementation of Trans-Pacific Partnership (TPP) provisions and other Amendments to Application Processes PHARMAC is pleased to announce that changes will
More informationGuidance for Industry
Guidance for Industry Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
More informationPROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS)
PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS) The Post-Graduates will acquire adequate scientific information regarding basic principles of Pharmaceutics including Cosmetology, Specialized drug
More informationUniversity of Asia Pacific (UAP) Department of Law and Human Rights
University of Asia Pacific (UAP) Department of Law and Human Rights COURSE OUTLINE Program LLB (Honors) Course Code Law 349: Cyber Law and Intellectual Property Law & Title Level 3 rd Year 2 nd Semester
More informationPELLISSIPPI STATE TECHNICAL COMMUNITY COLLEGE MASTER SYLLABUS. VISUALIZATION TECHNIQUES IDT 2630 (formerly IDT 1600)
PELLISSIPPI STATE TECHNICAL COMMUNITY COLLEGE MASTER SYLLABUS VISUALIZATION TECHNIQUES IDT 2630 (formerly IDT 1600) Class Hours: 3.0 Credit Hours: 3.0 Laboratory Hours: 3.0 Revised: Fall 06 NOTE: This
More informationROCHESTER INSTITUTE OF TECHNOLOGY COURSE OUTLINE FORM COLLEGE OF SCIENCE. Chester F. Carlson Center for Imaging Science
ROCHESTER INSTITUTE OF TECHNOLOGY COURSE OUTLINE FORM COLLEGE OF SCIENCE Chester F. Carlson Center for Imaging Science REVISED COURSE: COS-IMGS-241 Earth System Dynamics 1.0 Course Designations and Approvals
More informationAngelina College Technology and Workforce Division TECHNICAL DRAFTING SYLLABUS DFTG 1405 Instructional Syllabus
Angelina College Technology and Workforce Division TECHNICAL DRAFTING SYLLABUS DFTG 1405 Instructional Syllabus Date approved 8/21/18 Date revised 8/21/18 I. BASIC COURSE INFORMATION A. Course Description:
More informationU252 - Environmental Law Monday and Wednesday 11:00 a.m. -12:20 p.m. in SSPA 1165
U252 - Environmental Law Monday and Wednesday 11:00 a.m. -12:20 p.m. in SSPA 1165 Professor Joseph DiMento Office: 212E Social Ecology I Bldg. Office Hours: Tuesday 10:30 a.m. or by appointment Phone:(949)824-5102
More informationLuna Community College Media Art and Film Technology Associate of Applied Science Degree Curriculum Profile
Luna Community College Media Art and Film Technology Associate of Applied Science Degree 2012-2015 Curriculum Profile Content Page Program Goals 2 Approvals 2 Degree/Certificate Requirements. 3-4 Course
More informationCourse Form Revision
62 Course Form Revision For help filling out the form press F1 or look at the bottom of the screen. For additional instructions, see Course Form Instructions. Type of Action Revision Major revision of
More informationIB Course Syllabus 2015/16 Visual Arts (HL/SL)
IB Course Syllabus 2015/16 Visual Arts (HL/SL) Rocio Toral Time: Two-year programme Room: 111-112-114 DESCRIPTION: This course is intended for students with a serious interest in the visual arts and the
More informationProgressive Licensing and the Modernization of the Canadian Regulatory Framework
Progressive Licensing and the Modernization of the Canadian Regulatory Framework Workshop on Implementation of ICH Quality Guidelines Beijing, China 3-5 December, 2008 Mike Ward Health Canada 1 DISCLAIMER
More informationBID October - Course Descriptions & Standardized Outcomes
BID 2017- October - Course Descriptions & Standardized Outcomes ENGL101 Research & Composition This course builds on the conventions and techniques of composition through critical writing. Students apply
More informationDigital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver
Digital Health Jiban Khuntia, PhD Assistant Professor Business School University of Colorado Denver Digital Digital usually refers to something using digits, particularly binary digits. Examples: Digital
More informationEastern Illinois University New Course Proposal ART 1001, Drawing II
Eastern Illinois University New Course Proposal ART 1001, Drawing II Agenda Item #07-30 Effective Fall 2007 This format is to be used for all courses submitted to the Council on Academic Affairs and/or
More informationPROGRAM ASSESSMENT PLAN ~ through This document only needs to be updated when changes are made.
UNIT Department (if applicable) Degree/Program CHOOL OF NURING N/A Date Prepared June 30, 2017 Bachelor of cience in Nursing Date Revised Updated to New Form (6/23/15) Updated 5/25/2017 PROGRAM MIION Cell
More informationMECHANICAL ENGINEERING AND DESIGN 2017/18 SEMESTER 1 MODULES
Visual Communications ENG_4_542 Tuesday and Wednesday 2pm 4pm (Tues), 9.30am 11.30am (Weds) Students attend both sessions. The module aims a) to develop the capacities of observation and visualisation,
More informationCourse Goals/Objectives. The course has five objectives:
NYU Langone Medical Center Postdoctoral Program and the Sackler Institute for Graduate Biomedical Sciences Fundamentals of Technology Commercialization Course Leader: Dr. Sadhana Chitale Class meets Wednesdays,
More informationSubmission to the Department of Industry, Innovation and Science on the Productivity Commission s Final Report on Intellectual Property Arrangements
Submission to the Department of Industry, Innovation and Science on the Productivity Commission s Final Report on Intellectual Property Arrangements in Australia February 2017 1 Executive Summary Medicines
More information[Definitions of terms that are underlined are found at the end of this document.]
Policy Direction - Pharmaceutical Industry Relationships [Definitions of terms that are underlined are found at the end of this document.] Rationale and Relationship to Mission, Principles and Values The
More informationHealthTech: What does it mean for compliance?
HealthTech: What does it mean for compliance? May 2018 Agenda 11:15 AM 11:30 AM Introduction Kathleen Meriwether, Americas Leader - Life Sciences Fraud Investigation & Dispute Services, EY 11:30 AM 12:15
More informationROCHESTER INSTITUTE OF TECHNOLOGY COURSE OUTLINE FORM COLLEGE OF SCIENCE. Chester F. Carlson Center for Imaging Science
ROCHESTER INSTITUTE OF TECHNOLOGY COURSE OUTLINE FORM COLLEGE OF SCIENCE Chester F. Carlson Center for Imaging Science NEW COURSE: COS-IMGS-141 - Earth System Dynamics I 1.0 Course Designations and Approvals
More informationSOCIETY and TECHNOLOGY SOCIOLOGY 166 Spring 2013
SOCIETY and TECHNOLOGY SOCIOLOGY 166 Spring 2013 Dr. Timothy King Time: Monday 2:00-5:00PM Location: 50 Birge Office Hours: Wed 4:00-5:00PM, 483 Barrows Email: tim.king.phd@gmail.com Final Exam: May 14,
More informationPromoting innovation and improving access
NATIONAL ASSESSMENT TOOL TO ASSIST MEMBER STATES IN IMPLEMENTING THE GLOBAL STRATEGY AND PLAN OF ACTION ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY INTRODUCTION Promoting innovation and improving
More informationTuning-CALOHEE Assessment Frameworks for the Subject Area of CIVIL ENGINEERING The Tuning-CALOHEE Assessment Frameworks for Civil Engineering offers
Tuning-CALOHEE Assessment Frameworks for the Subject Area of CIVIL ENGINEERING The Tuning-CALOHEE Assessment Frameworks for Civil Engineering offers an important and novel tool for understanding, defining
More informationENTREPRENEURIAL FINANCE FINC-GB
ENTREPRENEURIAL FINANCE FINC-GB.3361.70 Professor Glenn A. Okun E-mail gokun@stern.nyu.edu Phone: 212 998 0780 COURSE DESCRIPTION This course seeks to provide an understanding of the financial and transactional
More informationProgramme Specification
Programme Specification Title: Bachelor of Final Award: Bachelor of (BArch Hons) With Exit Awards at: Certificate of Higher Education (CertHE) Diploma of Higher Education (DipHE) To be delivered from:
More informationIndustry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings
More informationAccess to Medicines, Patent Information and Freedom to Operate
TECHNICAL SYMPOSIUM DATE: JANUARY 20, 2011 Access to Medicines, Patent Information and Freedom to Operate World Health Organization (WHO) Geneva, February 18, 2011 (preceded by a Workshop on Patent Searches
More informationProgramme Title: BSc (Hons) Business Management (Full Time and Part Time) On Campus Division. URL None
Programme Specification Programme Title: BSc (Hons) Business (Full Time and Part Time) Awarding Institution: Teaching Institution: Division and/or Faculty/Institute: Professional accreditation University
More informationHealth Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities
Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities Aleksandra Torbica, Carlo Federici, Rosanna Tarricone Centre for Research on Health and
More informationCOM / ENG 267: Screenwriting Fundamentals -- Spring '14 Mon. & Wed :50am L & L 307
COM / ENG 267: Screenwriting Fundamentals -- Spring '14 Mon. & Wed. 10 11:50am L & L 307 Instructor: Maria Sanders Office Hours: Bouillon 225 Assistant Professor, Film and Video Studies Mon. / Tue. / Wed.
More informationAs our state s flagship university, KU s MISSION is to lift students and society
BOLD ASPIRATIONS As our state s flagship university, KU s MISSION is to lift students and society by educating LEADERS building healthy COMMUNITIES and making discoveries that will change the WORLD
More informationthe SPD company Dr Clive Simon, Principal, The SPD Company.
the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated
More informationIntegrated Scientific Advice Workshop: ISPOR Glasgow
Integrated Scientific Advice Workshop: ISPOR Glasgow Early Integrated Scientific Advice in Product Development: Get Real and Adapt to Accelerate Patient Access ICONplc.com Overview At today s patient-centered
More informationDIPLOMA IN FASHION DESIGN AND TECHNOLOGY Qualification code: DPFD19 - NQF Level 6 (360 credits)
DIPLOMA IN FASHION DESIGN AND TECHNOLOGY Qualification code: DPFD19 - NQF Level 6 (360 credits) SAQA ID: 100951, CHE NUMBER: H16/14237/HEQSF Campus where offered: Arts Campus REMARKS a. Admission requirement(s)
More informationCourse Outline. Code: COU751 Title: Mindfulness-Based Interventions in Counselling
Course Outline Code: COU751 Title: Mindfulness-Based Interventions in Counselling Faculty of Arts, Business and Law School of Social Sciences Teaching Session: Semester 1 Year: 2018 Course Coordinator:
More informationTechnology Competency Descriptors Students will be able to identify, compare, and utilize appropriate technological applications.
Technology Competency Descriptors Students will be able to identify, compare, and utilize appropriate technological Criteria Does Not Meet NA Identifies technological Demonstrates the use of technology
More informationIntellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
More informationOverview of Health Technology Assessment (HTA) from Asia Pacific Perspective
Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective Hong Li, PhD., MPH Group Director, Bristol-Myers Squibb Adjunct Associate Professor University of Cincinnati, USA; and DUKE-NUS
More informationCentre for the Study of Human Rights Master programme in Human Rights Practice, 80 credits (120 ECTS) (Erasmus Mundus)
Master programme in Human Rights Practice, 80 credits (120 ECTS) (Erasmus Mundus) 1 1. Programme Aims The Master programme in Human Rights Practice is an international programme organised by a consortium
More informationExploring Canada s early scientific advice: Global and Canadian context, CADTH and Health Canada perspectives. October 18, 2017
Exploring Canada s early scientific advice: Global and Canadian context, CADTH and Health Canada perspectives October 18, 2017 1 Today s par+cipants Panelist Panelist Panelist Panelist Don Husereau Health
More informationIM - Innovation Management
Coordinating unit: Teaching unit: Academic year: Degree: ECTS credits: 2017 295 - EEBE - Barcelona East School of Engineering 732 - OE - Department of Management BACHELOR'S DEGREE IN ELECTRICAL ENGINEERING
More informationPOLICY PHILOSOPHY DEFINITIONS AC.2.11 INTELLECTUAL PROPERTY. Programs and Curriculum. APPROVED: Chair, on Behalf of SAIT s Board of Governors
Section: Subject: Academic/Student (AC) Programs and Curriculum AC.2.11 INTELLECTUAL PROPERTY Legislation: Copyright Act (R.S.C., 1985, c.c-42); Patent Act (R.S.C., 1985, c.p-4); Trade-marks Act (R.S.C.
More informationMurrieta Valley Unified School District High School Course Outline December Course Title: Graphic Design III (Advanced Graphic Design)
I. Goals: Department: Visual and Performing Arts Murrieta Valley Unified School District High School Course Outline December 2013 Course Title: Graphic Design III (Advanced Graphic Design) Course Number:
More informationNHS Next Stage Review: Innovation
NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused
More informationTheir journey starts here
Their journey starts here Level 3 Tech-levels in Entertainment Technology Find out more at: aqa.org.uk/tech-levels Why teach our Tech-levels in Entertainment Technology You ll be at the cutting edge of
More informationDANIEL LASTER. HARVARD LAW SCHOOL, Cambridge Massachusetts, Visiting Student
EDUCATION DANIEL LASTER UNIVERSITY OF MICHIGAN LAW SCHOOL, Ann Arbor, Michigan, J.D. cum laude, May 1983. Honors and Activities: American Judicature Award, Legal Writing Environmental Law Society HARVARD
More informationTOPICS IN ENTREPRENEURIAL FINANCE FINC-UB
TOPICS IN ENTREPRENEURIAL FINANCE FINC-UB.0061.01 Professor Glenn A. Okun E-mail gokun@stern.nyu.edu Gokun1@mac.com Home page: www.stern.nyu.edu/~gokun Phone: 212 998 0780 COURSE DESCRIPTION This course
More informationPlease also note that this is an annual survey, so many of these questions will be familiar to you if you completed a survey last year.
Welcome to the 2016 National MLP Survey Thank you for agreeing to participate in this survey. You are receiving this survey because you have indicated to the National Center for Medical-Legal Partnership
More informationGuidance on the anonymisation of clinical reports for the purpose of publication in accordance with policy 0070
Guidance on the anonymisation of clinical reports for the purpose of publication in accordance with policy 0070 Stakeholder webinar 24 June 2015, London Presented by Monica Dias Policy Officer An agency
More informationCompetition Regulation Innovation. Dr. Marisa Miraldo
Competition Regulation Innovation Dr. Marisa Miraldo m.miraldo@imperial.ac.uk Brussels, 27th October, 2016 Outline The R&D and innovation challenge Current incentives HTA assessment: (weak) incentive for
More informationConvergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA
EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,
More informationUniversity of Engineering and Technology, Taxila Department of Civil Engineering
Course Instructor: Engr. Syed Saqib Mehboob University of Engineering and Technology, Taxila Department of Civil Engineering Course Title: Pre-requisite(s): Construction, Planning & Management (CE-304)
More informationGender pay gap reporting tight for time
People Advisory Services Gender pay gap reporting tight for time March 2018 Contents Introduction 01 Insights into emerging market practice 02 Timing of reporting 02 What do employers tell us about their
More informationCOURSE OUTLINE. School of Engineering Technology and Applied Science. Applied Biological and Environmental Science (ABES)
COURSE OUTLINE SCHOOL: School of Engineering Technology and Applied Science DEPARTMENT: Applied Biological and Environmental Science (ABES) PROGRAM: Architectural Technology COURSE TITLE: Architectural
More information